Back
Trevi Therapeutics Stock Predictions
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
TRVI
Trevi Therapeutics
Last Price:
$6.46
Seasonality Move:
20.26%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Trevi Therapeutics Stock Forecast
-
Over the next 52 weeks, Trevi Therapeutics has on average historically risen by 29.3% based on the past 5 years of stock performance.
-
Trevi Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Trevi Therapeutics Stock Undervalued?The current Trevi Therapeutics [TRVI] share price is $6.70. The Score for TRVI is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
TRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Trevi Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Trevi Therapeutics has on average historically risen by 29.3% based on the past 5 years of stock performance.
Trevi Therapeutics Stock Rating
Buy
69
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics overpriced?
-
Trevi Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Trevi Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
trevitherapeutics.com
52-Week Data
52-Week High:
7.39
52-Week Low:
2.30
Prediction Charts
Market Cap:
681.7M
Price in USD:
6.70
Volume:
1.2M
Beta:
0.57
Technical Analysis
SMA50:
6.09
SMA100:
5.11
SMA200:
4.05
52-Wk Change:
145.42%
Stock Predictions
-
Is Trevi Therapeutics stock public?Yes, Trevi Therapeutics is a publicly traded company.
-
What is the Trevi Therapeutics stock quote today?The Trevi Therapeutics stock price is 6.70 USD today.
-
How to buy Trevi Therapeutics stock online?You can buy Trevi Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-23 | 6.21 | 6.27 | 6.45 | 6.01 |
| Apr-24 | 6.25 | 6.35 | 6.38 | 6.18 |
| Apr-25 | 6.31 | 6.47 | 6.49 | 6.13 |
| Apr-28 | 6.54 | 6.59 | 6.70 | 6.39 |
| Apr-29 | 6.54 | 6.31 | 6.74 | 6.29 |
| Apr-30 | 6.25 | 6.91 | 7.02 | 6.14 |
| May-1 | 6.87 | 6.90 | 7.16 | 6.73 |
| May-2 | 7.00 | 6.99 | 7.24 | 6.78 |
| May-5 | 6.98 | 6.90 | 7.16 | 6.69 |
| May-6 | 6.80 | 6.58 | 6.85 | 6.56 |
| May-7 | 6.59 | 6.66 | 6.78 | 6.50 |
| May-8 | 6.67 | 6.60 | 6.78 | 6.37 |
| May-9 | 7.13 | 6.60 | 7.17 | 6.37 |
| May-12 | 6.61 | 6.70 | 6.83 | 6.55 |
Trevi Therapeutics Earnings
Trevi Therapeutics Earnings Report: Per Share Trevi Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Trevi Therapeutics Forecast Revenue Growth
Trevi Therapeutics Stock Analysis: Historical quarterly revenues per share for Trevi Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.07 per share.
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.